Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Clinical Hepatology ; (12): 1627-1630, 2020.
Artigo em Chinês | WPRIM | ID: wpr-822906

RESUMO

Nonalcoholic fatty liver disease (NAFLD) has become the most important chronic liver disease and is recognized as the hepatic manifestation of metabolic syndrome, which may progress to liver fibrosis, liver cirrhosis, and even hepatocellular carcinoma in the advanced stage. Gut microbiota, as important symbiotic organisms in the human body, affects metabolic function and may be closely associated with NAFLD, and the theory of gut-liver axis provides a theoretical basis for understanding that intestinal dysbacteriosis may cause liver pathological changes. This article explores the association between NAFLD and gut microbiota, so as to lay a theoretical foundation for the future research on the therapy for NAFLD targeting gut microbiota.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA